↓ Skip to main content

INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancer

Overview of attention for article published in BMC Cancer, October 2011
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (60th percentile)
  • Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
57 Dimensions

Readers on

mendeley
97 Mendeley
citeulike
2 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancer
Published in
BMC Cancer, October 2011
DOI 10.1186/1471-2407-11-430
Pubmed ID
Authors

Yi-Long Wu, Keunchil Park, Ross A Soo, Yan Sun, Karin Tyroller, David Wages, Guy Ely, James Chih-Hsin Yang, Tony Mok

Abstract

Previous research suggests the therapeutic cancer vaccine L-BLP25 potentially provides a survival benefit in patients with locally advanced unresectable stage III non-small cell lung carcinoma (NSCLC). These promising findings prompted the phase III study, INSPIRE, in patients of East-Asian ethnicity. East-Asian ethnicity is an independent favourable prognostic factor for survival in NSCLC. The favourable prognosis is most likely due to a higher incidence of EGFR mutations among this patient population.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 97 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Malaysia 1 1%
Unknown 96 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 26 27%
Student > Ph. D. Student 16 16%
Student > Master 10 10%
Student > Bachelor 7 7%
Student > Doctoral Student 7 7%
Other 16 16%
Unknown 15 15%
Readers by discipline Count As %
Medicine and Dentistry 29 30%
Agricultural and Biological Sciences 14 14%
Pharmacology, Toxicology and Pharmaceutical Science 8 8%
Immunology and Microbiology 6 6%
Nursing and Health Professions 5 5%
Other 17 18%
Unknown 18 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 October 2011.
All research outputs
#1,836,822
of 3,684,317 outputs
Outputs from BMC Cancer
#737
of 1,820 outputs
Outputs of similar age
#21,925
of 64,882 outputs
Outputs of similar age from BMC Cancer
#17
of 82 outputs
Altmetric has tracked 3,684,317 research outputs across all sources so far. This one is in the 45th percentile – i.e., 45% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,820 research outputs from this source. They receive a mean Attention Score of 2.2. This one has gotten more attention than average, scoring higher than 53% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 64,882 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.
We're also able to compare this research output to 82 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.